Konety B R, Metro M J, Melham M F, Salup R R
Department of Urology, University of Pittsburgh Medical Center, and Veterans Affairs Medical Center, Pittsburgh, PA 15213, USA.
Urol Int. 1999;62(1):26-30. doi: 10.1159/000030350.
In this article we report on our experience with the use of urine cytology for the screening and diagnosis of transitional cell carcinoma (TCC) of the bladder and upper urinary tracts at our institution between January 1987 and December 1995. A total of 76 patients were included in the study. All patients had voided urine cytology studies read as positive or highly suspicious for malignancy and no prior history of TCC of the urinary tract. All these patients subsequently underwent cystoscopy, bladder/ureteral barbotage cytology, random bladder biopsies, and radiographic studies of the upper tracts. Of the 76 patients with positive urine cytology, 53 also had barbotage urine cytologies which were positive. Six of these patients were found to have cystoscopically evident TCC of the bladder, and 1 patient had upper tract TCC. Three other patients subsequently went on to develop TCC of the bladder at 52, 89 and 111 months of follow-up. An additional patient was diagnosed with upper tract TCC at 12 months of follow-up. Among the 23 patients with negative bladder/ureteral barbotage cytology, 3 patients, 2 at the time of initial cystoscopy, and one 15 months later, showed evidence of TCC. Median patient follow-up was 97 (range 35-132) months. Thus of 76 patients with initial positive voided urine cytology studies, only 9 proved to have TCC at initial work-up, while 5 other patients were diagnosed with TCC during a median follow-up of 97 months. The statistical diagnostic values of the bladder/ureteral barbotage urine cytology studies at the time of cystoscopic work-up were: sensitivity 77%; specificity 31%; positive predictive value 13%, and negative predictive value 91%. Our data suggest that in patients without a previous history of TCC, the diagnostic value of bladder barbotage urine cytology is insignificant, and therefore not cost effective to be included as part of the routine work-up of TCC. Moreover, in patients with initially positive voided urine cytology and negative work-up, if the cytology subsequently becomes negative, the likelihood of the development of TCC is low. However, if the initially positive cytology continues to remain positive, there is a much higher probability of TCC being detected in this population.
在本文中,我们报告了1987年1月至1995年12月期间我们机构使用尿液细胞学检查对膀胱和上尿路移行细胞癌(TCC)进行筛查和诊断的经验。共有76例患者纳入研究。所有患者的排尿尿液细胞学检查结果均为恶性阳性或高度可疑,且既往无尿路TCC病史。所有这些患者随后均接受了膀胱镜检查、膀胱/输尿管灌洗细胞学检查、随机膀胱活检以及上尿路影像学检查。在76例尿液细胞学检查阳性的患者中,53例的灌洗尿液细胞学检查也呈阳性。其中6例患者膀胱镜检查发现膀胱有明显的TCC,1例患者有上尿路TCC。另外3例患者在随访52、89和111个月时随后发生了膀胱TCC。另有1例患者在随访12个月时被诊断为上尿路TCC。在23例膀胱/输尿管灌洗细胞学检查阴性的患者中,3例患者,2例在初次膀胱镜检查时,1例在15个月后,显示有TCC证据。患者的中位随访时间为97(范围35 - 132)个月。因此,在76例初次排尿尿液细胞学检查阳性的患者中,只有9例在初次检查时被证实患有TCC,而另外5例患者在中位随访97个月期间被诊断为TCC。膀胱镜检查时膀胱/输尿管灌洗尿液细胞学检查的统计诊断价值为:敏感性77%;特异性31%;阳性预测值13%,阴性预测值91%。我们的数据表明,在无TCC既往病史的患者中,膀胱灌洗尿液细胞学检查的诊断价值不大,因此作为TCC常规检查的一部分不具有成本效益。此外,在初次排尿尿液细胞学检查阳性但检查结果为阴性的患者中,如果细胞学检查随后变为阴性,则发生TCC的可能性较低。然而,如果最初阳性的细胞学检查持续呈阳性,则在该人群中检测到TCC的可能性要高得多。